ZAROXOLYN Drug Patent Profile
✉ Email this page to a colleague
When do Zaroxolyn patents expire, and when can generic versions of Zaroxolyn launch?
Zaroxolyn is a drug marketed by I3 Pharms and is included in one NDA.
The generic ingredient in ZAROXOLYN is metolazone. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zaroxolyn
A generic version of ZAROXOLYN was approved as metolazone by SANDOZ on December 19th, 2003.
Summary for ZAROXOLYN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 7 |
Patent Applications: | 4,155 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ZAROXOLYN? | ZAROXOLYN excipients list |
DailyMed Link: | ZAROXOLYN at DailyMed |
Recent Clinical Trials for ZAROXOLYN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Maryland | Phase 4 |
University of Maryland, Baltimore | Phase 4 |
University of Virginia | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ZAROXOLYN
US Patents and Regulatory Information for ZAROXOLYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |